{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:06:55Z","timestamp":1793815615895,"version":"4.6.1"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.neuropharm.2024.110202","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T03:27:03Z","timestamp":1730518023000},"page":"110202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Psilocybin reduces grooming in the SAPAP3 knockout mouse model of compulsive behaviour"],"prefix":"10.1016","volume":"262","author":[{"given":"James J.","family":"Gattuso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2222-9714","authenticated-orcid":false,"given":"Carey","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9262-3971","authenticated-orcid":false,"given":"Thibault","family":"Renoir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9688","key":"10.1016\/j.neuropharm.2024.110202_bib1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(09)60240-3","article-title":"Obsessive-compulsive disorder","volume":"374","author":"Abramowitz","year":"2009","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110202_bib2","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.biopsych.2016.04.023","article-title":"Increased metabotropic glutamate receptor 5 signaling underlies obsessive-compulsive disorder-like behavioral and striatal circuit abnormalities in mice","volume":"80","author":"Ade","year":"2016","journal-title":"Biol. Psychiatr."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110202_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0269881119897615","article-title":"Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer","volume":"34","author":"Agin-Liebes","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2024.110202_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuroscience.2015.11.009","article-title":"Using mice to model obsessive compulsive disorder: from genes to circuits","volume":"321","author":"Ahmari","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2024.110202_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1074633","article-title":"Psilocybin sex-dependently reduces alcohol consumption in C57BL\/6J mice","volume":"13","author":"Alper","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"S35","key":"10.1016\/j.neuropharm.2024.110202_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1192\/S0007125000297857","article-title":"Role of serotonin in obsessive-compulsive disorder","volume":"173","author":"Baumgarten","year":"1998","journal-title":"Br. J. Psychiatr."},{"issue":"7428","key":"10.1016\/j.neuropharm.2024.110202_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature11691","article-title":"Automated design of ligands to polypharmacological profiles","volume":"492","author":"Besnard","year":"2012","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110202_bib8","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ajmg.b.30897","article-title":"Sapap3 and pathological grooming in humans: results from the OCD collaborative genetics study","volume":"150","author":"Bienvenu","year":"2009","journal-title":"Am. J. Med. Genet. Part B: Neuropsychiatric Genetics"},{"key":"10.1016\/j.neuropharm.2024.110202_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-024-02786-0","article-title":"Striking long term beneficial effects of single dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming","author":"Brownstien","year":"2024","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.110202_bib10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00221-013-3579-0","article-title":"Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning","volume":"228","author":"Catlow","year":"2013","journal-title":"Exp. Brain Res."},{"issue":"26","key":"10.1016\/j.neuropharm.2024.110202_bib11","doi-asserted-by":"crossref","first-page":"9563","DOI":"10.1523\/JNEUROSCI.1701-11.2011","article-title":"Sapap3 deletion anomalously activates short-term endocannabinoid-mediated synaptic plasticity","volume":"31","author":"Chen","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110202_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/bs.pmbts.2015.02.009","article-title":"Insights into serotonin receptor trafficking: cell membrane targeting and internalization","volume":"132","author":"Darmon","year":"2015","journal-title":"Progress in Molecular Biology and Translational Science"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110202_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-26247-2","article-title":"Ketamine increases activity of a fronto-striatal projection that regulates compulsive behavior in SAPAP3 knockout mice","volume":"12","author":"Davis","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110202_bib14","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1021\/acschemneuro.2c00637","article-title":"Shared and distinct brain regions targeted for immediate early gene expression by ketamine and psilocybin","volume":"14","author":"Davoudian","year":"2023","journal-title":"ACS Chem. Neurosci."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110202_bib15","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/jclp.20083","article-title":"Pharmacotherapy for obsessive\u2010compulsive disorder","volume":"60","author":"Dougherty","year":"2004","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/j.neuropharm.2024.110202_bib16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110202_bib17","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41398-022-02103-9","article-title":"Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice","volume":"12","author":"Fadahunsi","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110202_bib18","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19r13085","article-title":"Women are at greater risk of OCD than men: a meta-analytic review of OCD prevalence worldwide","volume":"81","author":"Fawcett","year":"2020","journal-title":"J. Clin. Psychiatry"},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110202_bib19","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/2041-210X.12584","article-title":"BORIS: a free, versatile open\u2010source event\u2010logging software for video\/audio coding and live observations","volume":"7","author":"Friard","year":"2016","journal-title":"Methods Ecol. Evol."},{"key":"10.1016\/j.neuropharm.2024.110202_bib20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1146\/annurev.pharmtox.44.101802.121453","article-title":"Sex differences in pharmacokinetics and pharmacodynamics","volume":"44","author":"Gandhi","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2024.110202_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109689","article-title":"Acute administration of the NMDA receptor antagonists ketamine and MK-801 reveals dysregulation of glutamatergic signalling and sensorimotor gating in the Sapap3 knockout mouse model of compulsive-like behaviour","volume":"239","author":"Gattuso","year":"2023","journal-title":"Neuropharmacology"},{"issue":"n\/a","key":"10.1016\/j.neuropharm.2024.110202_bib22","article-title":"Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: a systematic review","author":"Gattuso","year":"2023","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110202_bib23","first-page":"257","article-title":"Obsessive-compulsive disorder","volume":"37","author":"Goodman","year":"2014","journal-title":"Psychiatr. Clin."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110202_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/02698811211073759","article-title":"Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: prospective 12-month follow-up","volume":"36","author":"Gukasyan","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110202_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-48637-9","article-title":"Aberrant habit formation in the Sapap3-knockout mouse model of obsessive-compulsive disorder","volume":"9","author":"Hadjas","year":"2019","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.neuropharm.2024.110202_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-020-0747-3","article-title":"Projection-specific deficits in synaptic transmission in adult Sapap3-knockout mice","volume":"45","author":"Hadjas","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110202_bib27","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/ijnp\/pyab040","article-title":"A complex impact of systemically administered 5-HT2A receptor ligands on conditioned fear","volume":"24","author":"Hags\u00e4ter","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2024.110202_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107933","article-title":"Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species","volume":"167","author":"Halberstadt","year":"2020","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110202_bib29","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neuropharm.2011.01.017","article-title":"Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens","volume":"61","author":"Halberstadt","year":"2011","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110202_bib30","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1177\/0269881110388326","article-title":"Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice","volume":"25","author":"Halberstadt","year":"2011","journal-title":"J. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110202_bib31","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1038\/npp.2009.29","article-title":"5-HT2A and 5-HT2C receptors exert opposing effects on locomotor activity in mice","volume":"34","author":"Halberstadt","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"17","key":"10.1016\/j.neuropharm.2024.110202_bib32","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022489118","article-title":"Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","volume":"118","author":"Hesselgrave","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110202_bib33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1089\/psymed.2022.0012","volume":"1","author":"Hibicke","year":"2023","journal-title":"Psychedelic Medicine"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110202_bib34","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1021\/acschemneuro.9b00493","article-title":"Psychedelics, but not ketamine, produce persistent antidepressant-like effects in a rodent experimental system for the study of depression","volume":"11","author":"Hibicke","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110202_bib35","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00213-022-06092-x","article-title":"Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents","volume":"239","author":"Jaster","year":"2022","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110202_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","article-title":"Long-term follow-up of psilocybin-facilitated smoking cessation","volume":"43","author":"Johnson","year":"2017","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110202_bib37","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1021\/acsptsci.3c00123","article-title":"Transient elevation of plasma glucocorticoids supports psilocybin-induced anxiolysis in mice","volume":"6","author":"Jones","year":"2023","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.neuropharm.2024.110202_bib38","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jpsychires.2022.05.024","article-title":"Valence processing alterations in SAPAP3 knockout mice and human OCD","volume":"151","author":"Kajs","year":"2022","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110202_bib39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrn.2015.8","article-title":"Neurobiology of rodent self-grooming and its value for translational neuroscience","volume":"17","author":"Kalueff","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110202_bib40","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1038\/s41380-023-02280-z","article-title":"Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats","volume":"28","author":"Kiilerich","year":"2023","journal-title":"Mol. Psychiatr."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.110202_bib41","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110202_bib42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41398-023-02323-7","article-title":"The Sapap3\u2212\/\u2212 mouse reconsidered as a comorbid model expressing a spectrum of pathological repetitive behaviours","volume":"13","author":"Lamothe","year":"2023","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110202_bib43","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1503\/jpn.180032","article-title":"Lateral orbitofrontal dysfunction in the Sapap3 knockout mouse model of obsessive\u2013compulsive disorder","volume":"44","author":"Lei","year":"2019","journal-title":"J. Psychiatr. Neurosci."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.110202_bib44","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3390\/brainsci11101353","article-title":"Reduced axon calibre in the associative striatum of the Sapap3 knockout mouse","volume":"11","author":"Lousada","year":"2021","journal-title":"Brain Sci."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110202_bib45","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/s41386-018-0307-2","article-title":"Impaired instrumental reversal learning is associated with increased medial prefrontal cortex activity in Sapap3 knockout mouse model of compulsive behavior","volume":"44","author":"Manning","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110202_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-88769-5","article-title":"Disruption of prepulse inhibition is associated with compulsive behavior severity and nucleus accumbens dopamine receptor changes in Sapap3 knockout mice","volume":"11","author":"Manning","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2024.110202_bib47","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbi.2023.09.004","article-title":"Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: an experimental, placebo-controlled study","volume":"114","author":"Mason","year":"2023","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110202_bib48","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1271\/bbb.90095","article-title":"Effects of Psilocybe argentipes on marble-burying behavior in mice","volume":"73","author":"Matsushima","year":"2009","journal-title":"Biosci., Biotechnol., Biochem."},{"issue":"47","key":"10.1016\/j.neuropharm.2024.110202_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh2399","article-title":"Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism","volume":"7","author":"Meinhardt","year":"2021","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110202_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pain.2005.06.020","article-title":"The case for the inclusion of female subjects in basic science studies of pain","volume":"117","author":"Mogil","year":"2005","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110202_bib51","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat. Neurosci."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110202_bib52","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder","volume":"67","author":"Moreno","year":"2006","journal-title":"J. Clin. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110202_bib53","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1037\/pha0000422","article-title":"Association of SAPAP3 allelic variants with symptom dimensions and pharmacological treatment response in obsessive\u2013compulsive disorder","volume":"30","author":"Naaz","year":"2022","journal-title":"Exp. Clin. Psychopharmacol"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110202_bib54","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2024.110202_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.113093","article-title":"Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice","volume":"401","author":"Odland","year":"2021","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2024.110202_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105046","article-title":"Utility of preclinical models in the study of psilocybin\u2013a comprehensive review","author":"Pedicini","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110202_bib57","first-page":"375","article-title":"Pharmacological treatment of obsessive-compulsive disorder","volume":"37","author":"Pittenger","year":"2014","journal-title":"Psychiatr. Clin."},{"key":"10.1016\/j.neuropharm.2024.110202_bib58","first-page":"1","article-title":"Effects of psilocybin, the 5-HT2A receptor agonist TCB-2, and the 5-HT2A receptor antagonist M100907 on visual attention in male mice in the continuous performance test","author":"Rahbarnia","year":"2023","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110202_bib59","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41386-021-01161-9","article-title":"Optogenetic inhibition of indirect pathway neurons in the dorsomedial striatum reduces excessive grooming in Sapap3-knockout mice","volume":"47","author":"Ram\u00edrez-Armenta","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2024.110202_bib60","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fphar.2013.00045","article-title":"Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved","volume":"4","author":"Renoir","year":"2013","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110202_bib61","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.euroneuro.2016.05.001","article-title":"Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens","volume":"26","author":"Rickli","year":"2016","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2024.110202_bib62","first-page":"1","article-title":"From compulsivity to compulsion: the neural basis of compulsive disorders","author":"Robbins","year":"2024","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110202_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96736-3","article-title":"LSD-stimulated behaviors in mice require \u03b2-arrestin 2 but not \u03b2-arrestin 1","volume":"11","author":"Rodriguiz","year":"2021","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.neuropharm.2024.110202_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214148","article-title":"Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 receptors in the head twitch response induced by 5-hydroxytryptophan and psilocybin: translational implications","volume":"23","author":"Shahar","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.neuropharm.2024.110202_bib65","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","volume":"109","author":"Shao","year":"2021","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110202_bib66","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41398-023-02456-9","article-title":"Effect of psilocybin on marble burying in ICR mice: role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder","volume":"13","author":"Singh","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2024.110202_bib67","series-title":"Mood and Anxiety Related Phenotypes in Mice: Characterization Using Behavioral Tests","first-page":"21","article-title":"Analysis of grooming behavior and its utility in studying animal stress, anxiety, and depression","author":"Smolinsky","year":"2009"},{"key":"10.1016\/j.neuropharm.2024.110202_bib68","first-page":"1","article-title":"Astrocyte\u2013neuron subproteomes and obsessive\u2013compulsive disorder mechanisms","author":"Soto","year":"2023","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.neuropharm.2024.110202_bib69","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1016\/j.neuron.2024.07.019","article-title":"Astrocyte Gi-GPCR signaling corrects compulsive-like grooming and anxiety-related behaviors in Sapap3 knockout mice","volume":"112","author":"Soto","year":"2024","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110202_bib70","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ajmg.b.32137","article-title":"Meta\u2010analysis of association between obsessive\u2010compulsive disorder and the 3\u2032 region of neuronal glutamate transporter gene SLC1A1","volume":"162","author":"Stewart","year":"2013","journal-title":"Am. J. Med. Genet. Part B: Neuropsychiatric Genetics"},{"key":"10.1016\/j.neuropharm.2024.110202_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1391689","article-title":"In vitro and in vivo metabolism of psilocybin's active metabolite psilocin","volume":"15","author":"Thomann","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110202_bib72","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12557","article-title":"Behavioral flexibility in a mouse model for obsessive\u2010compulsive disorder: impaired Pavlovian reversal learning in SAPAP3 mutants","volume":"18","author":"van den Boom","year":"2019","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.neuropharm.2024.110202_bib73","doi-asserted-by":"crossref","first-page":"g2183","DOI":"10.1136\/bmj.g2183","article-title":"Obsessive-compulsive disorder","volume":"348","author":"Veale","year":"2014","journal-title":"Br. Med. J."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110202_bib74","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.biopsych.2013.01.008","article-title":"Circuit-selective striatal synaptic dysfunction in the Sapap3 knockout mouse model of obsessive-compulsive disorder","volume":"75","author":"Wan","year":"2014","journal-title":"Biol. Psychiatr."},{"issue":"46","key":"10.1016\/j.neuropharm.2024.110202_bib75","doi-asserted-by":"crossref","first-page":"16685","DOI":"10.1523\/JNEUROSCI.2533-11.2011","article-title":"Sapap3 deletion causes mGluR5-dependent silencing of AMPAR synapses","volume":"31","author":"Wan","year":"2011","journal-title":"J. Neurosci."},{"issue":"7156","key":"10.1016\/j.neuropharm.2024.110202_bib76","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature06104","article-title":"Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice","volume":"448","author":"Welch","year":"2007","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110202_bib77","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/cne.20060","article-title":"Differential mRNA expression and protein localization of the SAP90\/PSD\u201095\u2013associated proteins (SAPAPs) in the nervous system of the mouse","volume":"472","author":"Welch","year":"2004","journal-title":"J. Comp. Neurol."},{"issue":"S3","key":"10.1016\/j.neuropharm.2024.110202_bib78","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1017\/S1092852900002479","article-title":"Neurobiology of obsessive-compulsive disorder: serotonin and beyond","volume":"12","author":"Westenberg","year":"2007","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neuropharm.2024.110202_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106223","article-title":"Mechanisms of pathogenesis and environmental moderators in preclinical models of compulsive-like behaviours","author":"Wilson","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2024.110202_bib80","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jad.2024.07.143","article-title":"Experience-dependent grooming microstructure alterations and gastrointestinal dysfunction in the SAPAP3 knockout mouse model of compulsive behaviour","volume":"363","author":"Wilson","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2024.110202_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107998","article-title":"Antidepressant-like effects of ketamine in a mouse model of serotonergic dysfunction","volume":"168","author":"Wilson","year":"2020","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.neuropharm.2024.110202_bib82","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.3390\/ijms23126713","article-title":"Effect of psilocybin and ketamine on brain neurotransmitters, glutamate receptors, DNA and rat behavior","volume":"23","author":"Wojtas","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1742","key":"10.1016\/j.neuropharm.2024.110202_bib83","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2017.0023","article-title":"Monoamine abnormalities in the SAPAP3 knockout model of obsessive-compulsive disorder-related behaviour","volume":"373","author":"Wood","year":"2018","journal-title":"Phil. Trans. Biol. Sci."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110202_bib84","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/acsptsci.0c00194","article-title":"The subjective effects of psychedelics are necessary for their enduring therapeutic effects","volume":"4","author":"Yaden","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110202_bib85","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/mp.2008.83","article-title":"Multiple rare SAPAP3 missense variants in trichotillomania and OCD","volume":"14","author":"Z\u00fcchner","year":"2009","journal-title":"Mol. Psychiatr."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082400371X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082400371X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T17:14:17Z","timestamp":1738430057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839082400371X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":85,"alternative-id":["S002839082400371X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110202","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.10.23.619763","asserted-by":"object"}]},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psilocybin reduces grooming in the SAPAP3 knockout mouse model of compulsive behaviour","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110202","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110202"}}